Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Antithyroid drugs are widely used in treatment of Graves' disease (GD), but after therapy
withdrawal, relapse rate is very high. The aim this trail is to evaluate the effects of
intrathyroid injection of dexamethasone combined with antithyroid drugs on patients with
newly diagnosed GD.